FDA Clears Laser Corp. Device for Capsulotomies

SALT LAKE CITY, Oct. 19 -- The US Food and Drug Administration has approved Laser Corp.'s Q-LAS 10 ophthalmic laser for use in the US. The laser, which is a Q-Switched YAG laser that is fully integrated into the arm of the slit lamp, allows surgeons who perform posterior capsulotomies to use the device for laser treatments as well as for standard examinations, the company said. The integration of the YAG laser into a standard slit lamp is achieved without compromising its optical quality, the company said. The Q-LAS 10 was developed with the help of Haag-Streit AG, in Switzerland, said Laser Corp. A.R.C. Laser Corp., the company's wholly owned subsidiary in Salt Lake City, will market and sell the product within the US.